Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00436709.
Last updated on July 23, 2008.
Information provided by National Cancer Institute (NCI)
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study: